2 Sources
[1]
What Alicia Boler Davis Had to 'Unlearn' From Jeff Bezos and Amazon to Lead Digital Pharmacy Alto
Hello and welcome to Modern CEO! I'm Stephanie Mehta, CEO and chief content officer of Mansueto Ventures. Each week this newsletter explores inclusive approaches to leadership drawn from conversations with executives and entrepreneurs, and from the pages of Inc. and Fast Company. If you received
[2]
What Alicia Boler Davis had to 'unlearn' from Jeff Bezos and Amazon to lead digital pharmacy Alto
Hello and welcome to Modern CEO! I'm Stephanie Mehta, CEO and chief content officer of Mansueto Ventures. Each week this newsletter explores inclusive approaches to leadership drawn from conversations with executives and entrepreneurs, and from the pages of Inc. and Fast Company. If you received
Share
Copy Link
Alicia Boler Davis, former Amazon executive, takes the helm at digital pharmacy Alto, launching an AI-driven enterprise platform to revolutionize medication delivery and pharmacy services.

In a move that caught many industry observers off guard, Alicia Boler Davis, a prominent figure in the business world, left her position at Amazon in 2022 to become the CEO of Alto, a digital pharmacy startup with an annual revenue of approximately $1 billion
1
2
. This transition marked a significant shift for Boler Davis, who had previously spent nearly 25 years at General Motors before joining Amazon in 2019.During her tenure at Amazon, Boler Davis made history as the first Black executive to join the company's senior leadership team, known as the S-team
1
2
. Her elevation to this prestigious group in 2020 placed her alongside influential figures such as then-CEO Jeff Bezos and current CEO Andy Jassy, who was leading Amazon Web Services at the time.Despite the prestige of her position at Amazon, Boler Davis saw an opportunity for greater impact at Alto. She explained her decision, stating, "Pharmacy is so antiquated, and there's so much opportunity in this space. I felt that I could have an impact. I could make a difference. That resonated with what I wanted to do at this point in my career"
1
2
. This move aligns with her self-description as a "builder at heart," suggesting a desire to create and innovate in a less established environment.Under Boler Davis's leadership, Alto has already begun to make waves in the pharmaceutical industry. In a recent development, the company launched Alto Technologies, an enterprise platform designed to revolutionize the delivery of medication to consumers
1
2
. This platform leverages artificial intelligence and automation to streamline services for various stakeholders in the pharmaceutical supply chain, including drugmakers, provider networks, hubs, and payors.Related Stories
The impact of Alto's AI-powered platform is already evident. Boler Davis cited an example where Alto's software significantly improved efficiency, cutting the "speed to fill" of a time-sensitive, specialty medication by half
1
2
. This achievement demonstrates the potential of AI and automation to address longstanding inefficiencies in the pharmaceutical industry.In transitioning from a tech giant like Amazon to a smaller, more agile startup, Boler Davis has had to adapt her leadership approach. While she brings valuable experience in scaling organizations, she's also had to "unlearn" certain aspects of leadership cultivated at Amazon under Jeff Bezos's influence. This adaptation highlights the different demands of leading a startup compared to a well-established corporation.
Summarized by
Navi
[1]
26 Jul 2024

10 Mar 2025•Business and Economy

31 Aug 2025•Business and Economy

1
Technology

2
Policy and Regulation

3
Technology
